Senior insider sale
See Remarks at ROCKET PHARMACEUTICALS, INC. — senior position signals high conviction
$79.4K
24.55K shares
What this filing means
SHAH GAURAV plans to sell 24.55K shares of ROCKET PHARMACEUTICALS, INC. valued at approximately $79.4K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 2/18/2026ACC: 0001959173-26-001175
DirectorOfficer· See Remarks
Since Jan 2019
24.55K
Shares to sell
$79.4K
Approx. market value
5.99K
Acquired (3 months)
1
Planned
2 completed
Securities Acquired — Last 3 Months1
Restricted Stock Vesting
Compensation
2/13/2026
5.99KTotal acquired5.99K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
2/13/2026 | Restricted Stock Vesting Compensation | 5.99K | — |
| Total | 5.99K | ||
Planned & Completed Dispositions3
Completed
—Completed
Units to sell
12.28K
Market value
$40.7K
2/13/2026
—Completed
Units to sell
6.28K
Market value
$18.7K
11/18/2025
Planned — Approximate Date
NASDAQPlanned
Units to sell
5.99K
Market value
$20.0K
2/18/2026
Total
Units
24.55K
Value
$79.4K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
2/13/2026 | 12.28K | $40.7K | — | Completed |
11/18/2025 | 6.28K | $18.7K | — | Completed |
| Planned — Approximate Date | ||||
2/18/2026 | 5.99K | $20.0K | NASDAQ | Planned |
| Total | 24.55K | $79.4K | ||